Amarin reported $309.27M in Stock for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Adamas Pharmaceuticals ADMS:US 8.68M 892K
Aerie Pharmaceuticals AERI:US $ 30.06M 0.65M
Alnylam Pharmaceuticals ALNY:US $ 110.95M 26.59M
Amarin AMRN:US $ 309.27M 36.81M
Arena Pharmaceuticals ARNA:US $ 0M 0M
Biocryst Pharmaceuticals BCRX:US $ 13.66M 3.82M
Epizyme EPZM:US 1.52M 447K
Esperion Therapeutics ESPR:US $ 33.97M 10.26M
GlaxoSmithKline GSK:LN 6244M 86M
Halozyme Therapeutics HALO:US $ 55.98M 2.58M
Heron Therapeutics HRTX:US $ 41.5M 1.3M
IONIS PHARMACEUT IONS:US $ 22.93M 1.17M
JAZZ PHA JAZZ:US $ 1137.85M 113.41M
Nektar Therapeutics NKTR:US $ 15.33M 0.71M
Neurocrine Biosciences NBIX:US $ 25.5M 2.8M
Novartis NOVN:VX SF 6885M 226M
Teva Pharmaceutical Industries TEVA:US $ 4167M 195M